MedCity News July 27, 2021
Anuja Vaidya

The hedge fund SS&C Technologies Holdings will be the majority stakeholder, while the two payers will each hold a minority interest in the PBM, dubbed DomaniRx. The joint venture will develop a claims adjudication platform to support its operations.

Anthem and Humana have entered into a joint venture with hedge fund and private equity administrator SS&C Technologies Holdings to create DomaniRx, a pharmacy benefit manager.

SS&C Technologies holds an 80.2% interest in the joint venture, while Louisville, Kentucky-based Humana and Indianapolis-based Anthem each hold a minority interest.

The joint venture will develop a cloud-native, application programming interface-driven claims adjudication platform to support its operations. DomaniRx will be a full-service pharmacy benefits manager, which are companies that manage prescription drug benefits...

Today's Sponsors

Transcarent
SalesSparx
Canton & Company

Today's Sponsors

Oscar
Curation Health

Today's Sponsor

TripleTree

 
Topics: Insurance, Investments, Payer, Pharma, Pharma / Biotech, Trends
Getting strategic about new-product submissions in the pharma industry
Venture firms warn R&D funding for new drugs will 'drop off a cliff' if Dem bill approved
Contentious report suggests safety net hospitals leveraging discounts to pocket strong gains from cancer drugs
340B hospitals mark up cancer drugs 3.8X for commercially insured patients, study finds
Report claims 340B hospitals are leveraging discounts to increase profits from cancer drugs